Levemir PenFill Cartridges

Levemir (insulin detemir) is a long-acting insulin used to help control blood sugar levels in people with diabetes. It provides steady, 24-hour blood sugar regulation and is typically used once or twice daily. Levemir Penfill cartridges are designed for use with compatible insulin pens, offering a convenient and precise way to administer insulin.

Benefits:

• Provides long-lasting blood sugar control for up to 24 hours.
• Can be taken once or twice daily, depending on individual needs.
• Reduces the risk of blood sugar fluctuations compared to short-acting insulins.
• Lower risk of weight gain compared to some other long-acting insulins.
• Compatible with Novo Nordisk insulin pens for easy dosing.

Dosage:

• Typically injected once daily or twice daily, as prescribed by a doctor.
• Dose is individualized based on blood sugar levels, lifestyle, and other diabetes medications.
• Must be used with a meal plan and regular blood sugar monitoring.

Warnings and Precautions:

• Not for use in diabetic ketoacidosis (DKA)—use rapid-acting insulin instead.
• May cause low blood sugar (hypoglycemia); monitor regularly.
• Inform your doctor if you have kidney, liver, or heart disease.
• Do not mix with other insulins in the same injection.
• Rotate injection sites to prevent lipodystrophy (skin thickening or lumps).

Usage Instructions:

• Insert the cartridge into a compatible insulin pen.
• Check the insulin—it should be clear and colorless.
• Prime the pen as directed before injecting.
• Inject subcutaneously in the abdomen, thigh, or upper arm.
• Rotate injection sites to avoid skin irritation.

Storage Information:

• Unopened cartridges: Store in the refrigerator (2°C to 8°C); do not freeze.
• In-use cartridges: Store at room temperature (below 30°C) for up to 42 days.
• Keep away from direct heat and sunlight.
• Do not use if expired or if the insulin appears cloudy.

Common Side Effects:

• Low blood sugar (dizziness, sweating, shakiness).
• Injection site reactions (redness, swelling, itching).
• Mild weight gain.
• Skin thickening or lumps at injection sites.
• Swelling in hands or feet (fluid retention).

More information about Levemir

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide